Skip to main content

Table 1 Patient characteristics of 19 patients with IOPD

From: Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy

Patient no. (n = 19)

Sex

GA, week, BBW (kg)

Age at referral (day)

Age at first ERT (day)

End of study age (year)

GAA mutation

1

F

37, 3.2

18

18

9.5

c.1411_1414del, (E471fsX5), heterozygous

c.872T → C, (p.L291P) heterozygous

2

M

38, 3.5

15

15

8.4

c.1935 C → A, (p.D645E), homozygous

c.1726 G → A, (p.G576S), homozygous

3

M

39, 3.3

9

9

8.4

c.1935 C → A, (p.D645E), heterozygous

c.2303 C → T, (p.P768L), heterozygous

4

M

38, 3.1

12

12

8

c.1396 G → T, (p.V466F), heterozygous

c.1935 C → A, (pD645E), heterozygous

5

F

39, 3.0

9

9

7.5

c.1935 C → A, (p.D645E), homozygous

c.1726 G → A, (p.G576S), homozygous

6

F

39, 3.1

8

23

6.5

c.2238 G → C, (p.W746C), heterozygous

c.2237 G → A, (p.W746X), heterozygous

c.1726 G → A, (p.G576S), heterozygous

7

F

34, 2.2

12

12

6.5

c.1935 C → A, (pD645E), heterozygous

IVS7 + 2T → C, heterozygous

c.1726 G → A, (p.G576S), heterozygous

8

M

39, 3.7

7

7

6.4

IVS7 + 2T → C, heterozygous

c.1935 C → A, (p.D645E), heterozygous

c.1726 G → A, (p.G576S), heterozygous

9

F

39, 2.9

13

13

6

c.1082 C → T, (p.P361L), heterozygous

c.1935 C → A, (p.D645E), heterozygous

c.1726 G → A, (p.G576S), heterozygous

10

F

39, 2.9

10

10

5.7

c.1935 C → A, (p.D645E), homozygous

c.1726 G → A, (p.G576S), homozygous

11

F

41, 2.6

6

6

5.6

c.1935 C → A, (p.D645E), homozygous

c.1726 G → A, (p.G576S), homozygous

12

F

36, 3.3

8

8

4.8

c.1411_1414del, (E471fsX5), heterozygous

c.1935 C → A, (pD645E), heterozygous

c.1726 G → A, (p.G576S), heterozygous

13

M

39, 2.5

13

13

4.6

c.1726 G → A, (p.G576S), heterozygous

c.1935C → A, (pD645E), heterozygous

c.2274insC, (p.G759fs), heterozygous

14

F

39, 3.1

7

8

2.4

c.1935 C → A, (p.D645E), homozygous

c.1726 G → A, (p.G576S), homozygous

15

F

38, 3.5

7

9

3.1

c.1411_1414del, (E471fsX5), heterozygous

c.752C > T;c.761 C > T,p.S251L; S254L

c.1843 G > A,p.G615R

16

F

37, 3.1

9

10

3

c.1636 + 10 C > T

c.2024_2026del,p.N675del

c.241 C > T,p.Q81*

17

F

38, 3.6

14

14

2.8

c.2228 A > C,p.Q743P

c.1726 G → A, (p.G576S), heterozygous

c.1935C → A, (pD645E), heterozygous

18

M

39, 3.1

6

6

2.5

c.2238 G → C, (p.W746C), heterozygous

c.1726 G → A, (p.G576S), heterozygous

c.1935C → A, (pD645E), heterozygous

19

M

38, 3.8

7

8

2

c.1935 C → A, (p.D645E), homozygous

c.1726 G → A, (p.G576S), homozygous

Mean (SD)

  

10.0 (3.42)

11.05 (4.31)

5.46 (2.33)

 
  1. F, female; M, male; GA, gestational; BBW, birth body weight; and SD: standard deviation